The role of evidence in the decline of antibiotic use for common respiratory infections in primary care

Lancet Infectious Diseases

Volumn 7, Issue 11, 2007, Pages 749-756

  Cosby, Jarold L ^a,b,c   Francis, Nick ^c   Butler, Christopher C ^c  

^a BROCK UNIVERSITY   (Canada)

^b CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CONJUNCTIVITIS; DRUG INDICATION; DRUG USE; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HUMAN; LARYNGITIS; OTITIS MEDIA; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SINUSITIS; SORE THROAT; UNITED KINGDOM; UNITED STATES;

EID: 35349002761     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70263-3     Document Type: Note

References (108)

1. Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance. The path of least resistance (1998), Department of Health, London
2. McCormick A., Fleming D., and Charlton J. Morbidity statistics from general practice. Fourth National Study 1991-1992 (1995), H M Stationery Office, London
3. Frischer M., Heatlie H., Norwood J., Bashford J., Millson D., and Chapman S. Trends in antibiotic prescribing and associated indications in primary care from 1993 to 1997. J Public Health Med 23 (2001) 69-73
4. Brunner E., and Marmot M. Social organization, stress, and health. In: Marmot M., and Wilkonson R. (Eds). The social determinants of health (1999), Oxford University Press, Oxford 7-42
5. Marmot M. Introduction. In: Marmot M., and Wilkonson R. (Eds). The social determinants of health (1999), Oxford University Press, Oxford 1-16
6. Cutler D., and Miller G. The role of public health improvements in health advances: the twentieth-century United States. Demography 42 (2005) 1-22
7. Schulman S. The history of paediatric infections diseases. Pediatr Res 55 (2004) 163-176
8. Olshansky S., Passaro D., Hershow R., et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352 (2005) 1138-1145
9. Bi P., Whitby M., Walker S., and Parton K. Trends in mortality rates for infectious and parasitic diseases in Australia: 1907-1997. Intern Med J 33 (2003) 152-162
10. Armstrong G., Conn L., and Pinner R. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281 (1999) 61-65
11. Stein C., Inoue M., and Fat D. The global mortality of infectious and parasitic diseases in children. Semin Pediatr Infect Dis 15 (2004) 125-129
12. Ferriman A. BMJ readers choose the 'sanitary revolution' as greatest medica advance since 1840. BMJ 334 (2007) 111
13. Davey P., Pagliari C., and Hayes A. The patient's role in the spread and control of bacterial resistance to antibiotics. Clin Microbiol Infect 8 suppl 2 (2002) 43-68
14. Cars O., and Liljequist B. A report on Swedish antibiotic utilisation and resistance in human medicine (2004), STRAMA, Swedish Institute for Infectious Disease Control, Solna
15. Metlay J., Stafford R., and Singer D. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 158 (1998) 1813-1818
16. McManus P., Hammond M., Whicker S., Primrose J., Mant A., and Fairall S. Antibiotic use in the Australian community, 1990-1995. Med J Aust 167 (1997) 124-127
17. McCaig L., and Hughes J. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 273 (1995) 214-219
18. Stott N., and West R. Randomised controlled trial in patients with cough and purulent sputum. BMJ 2 (1976) 556-559
19. Arroll B., and Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 3 (2005) CD000247.
20. Del Mar C., Glasziou P., and Spinks A. Antibiotics for sore throat. Cochrane Database of Syst Rev 4 (2006) CD000023.
21. Williams J., Aguilar C., Cornell J., et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2 (2003) CD000243.
22. Glasziou P., Del Mar C., Sanders S., and Hayem M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 1 (2004) CD000219.
23. Smucny J., Fahey T., Becker L., and Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 4 (2004) CD000245.
24. Sheikh A., Hurwitz B., and Cave J. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2 (2000) CD001211.
25. Reveiz L., Cardona A., and Ospina E. Antibiotics for acute laryngitis in adults. Cochrane Database Syst Rev 1 (2005) CD004783.
26. Scott J., Cohen D., DiCicco-Bloom B., Orzano A., Jaen C., and Crabtree B. Antibiotic use in acute respiratory infections and the ways patients pressure physicians for a prescription. J Fam Pract 50 (2001) 853-858
27. German-Fattal M., and Mosges R. How to improve current therapeutic standards in upper respiratory infections: value of fusafungine. Curr Med Res Opin 20 (2004) 1769-1776
28. Quach C., Collet J., and LeLorier J. Acute otitis media in children: a retrospective analysis of physician prescribing patterns. Br J Clin Pharmacol 57 (2004) 500-505
29. Jelinski S., Parfrey P., and Hutchinson J. Antibiotic utilisation in community practices: guideline concurrence and prescription necessity. Pharmacoepidemiol Drug Saf 14 (2005) 319-326
30. Mohan S., Dharamraj K., Dindial R., et al. Physician behaviour for antimicrobial prescribing for paediatric upper respiratory tract infections: a survey in general practice in Trinidad, West Indies. Ann Clin Microbiol Antimicrob 3 (2004) 11
31. Finch R., Metlay J., Davey P., and Baker L. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 4 (2004) 44-53
32. Goossens H., Ferech M., Vander Stichele R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
33. Wrigley T., Tinto A., and Maheed A. Age and sex-specific antibiotic prescribing patterns in general practice in England and Wales, 1994 to 1998. Health Stat Q Summer (2002) 14-20
34. Smith G., Smith S., Heatlie H., et al. What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? Description of trends in antimicrobial usage using the General Practice Research Database. J Public Health (Oxf) 26 (2004) 359-364
35. Halasa N., Griffin M., Zhu Y., and Edwards K. Differences in antibiotic prescribing patterns for children younger than five years in the three major outpatient settings. J Pediatr 144 (2004) 200-205
36. Rutschmann O., and Domino M. Antibiotics for upper respiratory tract infections in ambulatory practice in the United States, 1997-1999: does physician specialty matter?. J Am Board Fam Pract 17 (2004) 196-200
37. Cantrell R., Young A., and Martin B. Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis. Clin Ther 24 (2002) 170-182
38. Thorpe J., Smith S., and Trygstad T. Trends in emergency department antibiotic prescribing for acute respiratory tract infections. Ann Pharmacother 38 (2004) 928-935
39. Ashworth M., Latinovic R., Charlton J., Cox K., Rowlands G., and Gulliford M. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database. J Public Health (Oxf) 26 (2004) 268-274
40. McCaig L., and Burt C. National Hospital Ambulatory Medical Care Survey: 2002 emergency department summary. Adv Data 340 (2004) 1-34
41. Ciesla G., Leader S., and Stoddard J. Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001. Respir Med 98 (2004) 1093-1101
42. Linder J., Bates D., and Platt R. Antivirals and antibiotics for influenza in the United States 1995-2002. Pharmacoepidemiol Drug Saf 14 (2005) 531-536
43. Lark K., and Phillips C. Do patients get the bets deal when antibiotics are prescribed out of hours?. J Accid Emerg Med 14 (1997) 159-162
44. Del Mar C., and Askew D. Building family/general practice research capacity. Ann Fam Med 2 suppl 2 (2004) S35-S40
45. Scott A., Watson M., and Ross S. Eliciting preferences of the community for out of hours care provided by general practitioners: a stated preference discrete choice experiment. Soc Sci Med 56 (2003) 803-814
46. Lindbaek M., Francis N., Cannings-John R., Butler C., and Hjortdahl P. Clinical course of suspected viral sore throat in young adults: cohort study. Scand J Prim Health Care 24 (2006) 93-97
47. Spurling G., Del Mar C., Dooley L., and Foxlee R. Delayed antibiotics for symptoms and complications of respiratory infections. Cochrane Database Syst Rev 4 (2004) CD004417.
48. Little P., Gould C., Williamson I., Warner G., Gantley M., and Kinmonth A. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 315 (1997) 350-352
49. Dowell J., Pitkethly M., Bain J., and Martin S. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract 51 (2001) 200-205
50. Arroll B., Kenealy T., and Kerse N. Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. Br J Gen Pract 53 (2003) 871-877
51. Edwards M., Dennison J., and Sedgwick P. Patients' responses to delayed antibiotic prescription for acute upper respiratory tract infections. Br J Gen Pract 53 (2003) 845-850
52. Martin C., Njike V., and Katz D. Back-up antibiotic prescriptions could reduce unnecessary antibiotic use in rhino sinusitis. J Clin Epidemiol 57 (2004) 429-434
53. Siegel R., Kiely M., Bien J., et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics 112 (2003) 527-531
54. Arrol B. Antibiotics for upper respiratory tract infections; an overview of Cochrane reviews. Respir Med 99 (2005) 255-261
55. Fleming D., Ross A., Cross K., and Kendall H. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 53 (2003) 778-783
56. Grijalva C., Poehling K., Nuorti J., et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118 (2006) 865-873
57. Ashworth M., Charlton J., Latinovic R., and Gulliford M. Age-related changes in consultations for acute respiratory infections, 1995-2000. Data from the UK General Practice Research Database. J Clin Pharm Ther 31 (2006) 461-467
58. Sharland M., Kendal H., Yeates D., et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: trim trend analysis. BMJ 331 (2005) 328-329
59. Unsworth L., and Walley T. Trends in primary care antibiotic prescribing in England 1994-1998. Pharmacoepidemiol Drug Saf 10 (2001) 309-314
60. Finkelstein J., Stille C., Nordin J., et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics 112 (2003) 620-627
61. Searle P. Why antibiotics propaganda may cause extra deaths. Pulse 64 (2004) 25
62. Price D., Honeybourne D., Little P., et al. Community acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice. Respir Med 98 (2004) 798-800
63. Little P., Watson L., Morgan S., and Williamson I. Antibiotic prescribing and admission with major supportive complications of respiratory tract infections: a data linkage study. Br J Gen Pract 52 (2002) 187-190
64. Van Zuijlen D., Schilder A., Van Balen F., and Hoes A. National differences in incidence of acute masoiditis: relationship to prescribing patterns of antibiotics for acute otitis media?. Paediatr Infect Dis J 20 (2001) 140-144
65. Simpson J., Macfarlane J., Watson J., and Woodhead M. A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Reseach Committee and Public Health Laboratory Service. Thorax 55 (2000) 1040-1045
66. Dunn N., Lane D., Everitt H., and Little P. Use of antibiotics for sore throat and incidence of quinsy. Br J Gen Pract 57 (2007) 45-49
67. Mainous A., Saxena S., Hueston W., Everett C., and Majeed A. Ambulatory antibiotic prescribing for acute bronchitis and cough and hospital admissions for respiratory infections: time trends analysis. J R Soc Med 99 (2006) 358-362
68. Wood F, Simpson S, Butler C. Socially responsible antibiotic choices in primary care: a qualitative study of GP's decisions to prescribe broad spectrum and fluroquinolone antibiotics. Fam Pract (in press).
69. Simpson S., Wood F., and Butler C. General practitioners' perceptions of antimicrobial resistance: a qualitative study. J Antimicrob Chemother 59 (2007) 292-296
70. Metlay J., Stafford R., and Singer D. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 158 (1998) 1813-1818
71. Watson R., Dowell S., Jayaraman M., Keyserling H., Kolczak M., and Schwartz B. Antimicrobial use for paediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Paediatrics 104 (1999) 1251-1257
72. Arnold S., To T., McIsaac W., and Wang E. Antibiotic prescribing for upper respiratory tract infection: the importance of diagnostic uncertainty. J Pediatr 146 (2005) 222-226
73. Jelinski S., Parfrey P., and Hutchinson J. Antibiotic utilisation in community practices: guideline concurrence and prescription necessity. Pharmacoepidemiol Drug Saf 14 (2005) 319-326
74. Andre M., Schwan A., and Odenhot I. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scan J Infect Dis 36 (2004) 192-197
75. Engstrom S., Molstad S., Lindstrom K., Nilsson G., and Borgquist L. Excessive use of rapid tests in respiratory tract infections in Swedish primary health care. Scan J Infect Dis 36 (2004) 213-218
76. Mazzaglia G., Caputi A., Rossi A., et al. Exploring patient and doctor related variables associated with antibiotic prescribing for respiratory infections in primary care. Eur J Clin Pharmacol 59 (2003) 651-657
77. Mainous A., Hueston W., Davis M., and Pearson W. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health 93 (2003) 1910-1914
78. Steinman M., Landefeld C., and Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 289 (2003) 719-725
79. Linder J., Huang E., Steinman M., Gonzales R., and Stafford R. Fluroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118 (2005) 259-268
80. McIssac W., Goel V., To T., and Low D. The validity of a sore throat score in family practice. CMAJ 163 (2000) 811-815
81. Wise R., Hart T., Cars O., et al. Antimicrobial resistance. Is it a major threat to public health?. BMJ 317 (1998) 609-610
82. Butler C., Hillier S., Roberts Z., Dunstan F., Howard A., and Palmer S. Antibiotic-resistant infections in primary care are symptomatic for longer and increased workload: outcomes for patient with E coli UTIs. Br J Gen Pract 56 (2006) 686-692
83. Livermore D., and Hawkey P. CTX-M: changing the face of ESBLS in the UK. J Antimicrob Chemother 56 (2005) 451-454
84. Chiew Y., Yeo S., Hall L., and Livermore D. Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae. J Antimicrob Chemother 41 (1998) 247-251
85. Levin B., Lipsitch M., Perrot V., et al. The population genetics of antibiotic resistance. Clin Infect Dis 24 suppl 1 (1997) S9-S16
86. Livermore D. Can better prescribing turn the tide of resistance?. Nat Rev Microbiol 2 (2004) 73-78
87. Seppala H., Klaukka T., Vuopio-Varkila J., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337 (1997) 441-446
88. Kataja J., Huovinen P., Muotiala A., et al. Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 177 (1998) 786-789
89. Soares S., Kristinsson K., Musser J., and Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 168 (1993) 158-163
90. Arason V., Kristinsson K., Sigurdsson J., Stefansdottir G., Molstad S., and Gudmundsson S. Do microbials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 313 (1996) 387-391
91. Guillemot D., Varon E., Bernede C., et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 41 (2005) 930-938
92. Butler C., Dunstan F., Heginbothom M., et al. Containing antibiotic resistance: demonstration of decreased antibiotic resistant coliform urinary tract infections with reduction in antibiotic prescribing by general medical practices. Br J Gen Pract 57 (2007) 785-792
93. Fujita K., Murono K., Yoshikawa M., and Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis 13 (1994) 1075-1078
94. Hillier S., Roberts Z., Dunstan F., Butler C., Howard A., and Palmer S. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 60 (2007) 92-99
95. Hawkings N., Wood F., and Butler C. Public attitudes towards bacterial resistance: a qualitative study. J Antimicrob Chemother 59 (2007) 1155-1160
96. McNulty C., Richards J., Livermore D., et al. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 58 (2006) 1000-1008
97. Levine M., and Cosby J. Valuing knowledge and the knowledge of values: understanding guideline-incongruent prescribing. J Clin Pharmacol 42 (2002) 475-476
98. Gonzales R., Corbett K., Leeman-Castillo B., et al. The "minimizing antibiotic resistance in Colorado" project: impact of patient education in improving antibiotic use in private office practices. Health Serv Res 40 (2005) 101-116
99. Rubin M., Bateman K., Alder S., Donnelly S., Stoddard G., and Samore M. A multifaceted intervention to improve antimicrobial prescribing for upper respiratory tract infections in a small rural community. Clin Infect Dis 40 (2005) 546-553
100. Marshall T., and Mohammed M. Understanding variation in quality improvement: the treatment of sore throats in primary care. Fam Pract 20 (2003) 69-73
101. Levine M., and Cosby J. The place for prescribing guidelines and the means of their dissemination. Can J Clin Pharmacol 8 suppl A (2001) 29-33
102. Butler C., Kinnersley P., Prout H., Rollnick S., Edwards A., and Elwyn G. Antibiotics and shared decision-making in primary care. J Antimicrob Chemother 48 (2001) 435-440
103. Watson R., Dowell S., Jayaraman M., Keyserling H., Kolczak M., and Schwartz B. Antimicrobial use for paediatric upper respiratory infections: reported practice, actual practice and patient beliefs. Paediatrics 104 (1999) 1251-1257
104. Belongia E., and Schwartz B. Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ 317 (1998) 668-671
105. Butler C., Rollnick S., Pill R., Maggs-Rapport F., and Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 317 (1998) 637-642
106. Barry C., Bradley C., Britten N., Stevenson F., and Barber N. Patients' unvoiced agendas in general practice consultations: qualitative study. BMJ 320 (2000) 1246-1250
107. Finch R., and Hunter P. Antibiotic resistance-action to promote new technologies: report on an EU intergovernmental conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 58 suppl 1 (2006) i3-i22
108. Norrby S., Nord C., and Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5 (2005) 115-119